文献速递甲状腺疾病

多发性DUOX2变异致先天性甲状腺功能减退症的分子与临床特征

Molecular and Clinical Features of Congenital Hypothyroidism Due to Multiple DUOX2 Variants.
PubMed 文献 · Thyroid · 2024-06-07

研究对255例先天性甲状腺功能减退症(CH)患者筛查11个已知致病基因,鉴定出DUOX2的24个致病变异,其中21例携带多个DUOX2致病变异且无其他基因变异。这些患者多表现为暂时性CH,基因型与临床严重程度无显著相关,但停药后长期随访中部分患者出现复发。

要点

  • 21例携带多个DUOX2致病变异且无其他基因变异的CH患者中,19例接受左甲状腺素治疗,停药年龄为9个月至21.4岁。
  • 3例患者在停药间期分别为6个月、8个月和10年后需要重新治疗。
  • DUOX2无功能/无功能、无功能/低功能及低功能/低功能变异患者之间临床严重程度无差异。

核心结论

  • 多个DUOX2致病变异患者通常表现为暂时性CH,无显著基因型-表型相关性,且首次证明这些患者在长期无药间期后存在复发甲状腺功能减退症的风险。

研究设计与样本

  • 对255例CH患者筛查11个已知致病基因的罕见变异,并对部分功能未知变异进行体外检测,临床分析纳入携带多个DUOX2致病变异且无其他基因致病变异的患者。

主要发现

  • 在63例患者中鉴定出DUOX2的24个致病变异、2个良性变异和7个意义未明变异,致病变异包括3个错义替换和1个移码变异此前未与CH关联。
  • 21例患者携带多个DUOX2致病变异且无其他致病基因变异,其中3例为纯合变异;家系分析、长读长扩增子测序和单倍型定相确认14例为复合杂合,其余4例等位基因位置无法确定。
  • 21例中19例接受左甲状腺素治疗,停药年龄为9个月至21.4岁;3例在无药间期分别为6个月、8个月和10年后需要重新治疗。
  • DUOX2无功能/无功能、无功能/低功能及低功能/低功能变异患者之间临床严重程度无差异。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Background: DUOX2 is one of the major causative genes of congenital hypothyroidism (CH). Still, the mutation spectrum and clinical outcomes of biallelic DUOX2 variants are not fully understood. This study aimed to elucidate the molecular features and long-term clinical manifestations of CH caused by multiple pathogenic DUOX2 variants. Methods: A total of 255 patients with CH were screened for rare variants of 11 known causative genes. DUOX2 variants were classified according to their protein structure and residual activity. In vitro assays were performed for several variants of unknown functions. Clinical analyses were conducted for patients with multiple pathogenic variants of DUOX2 but not of other genes. Results: We identified 24 pathogenic variants of DUOX2, together with two benign variants and seven variants of uncertain significance, in 63 patients. The pathogenic variants included three missense substitutions and one frameshift variant that have not yet been linked to CH. Twenty-one patients carried multiple pathogenic DUOX2 variants without any other pathogenic gene variants. Three of the 21 patients harbored homozygous variants. Family analysis, long-read amplicon sequencing, and haplotype phasing confirmed compound heterozygosity of the DUOX2 variants in 14 patients, whereas the allelic positions of the variants in the remaining four patients could not be determined. Of the 21 patients, 19 were treated with levothyroxine; their ages at drug withdrawal ranged from 9 months to 21.4 years. Three patients required retreatment after drug-free intervals of 6 months, 8 months, and 10 years. There were no differences in clinical severity among patients with DUOX2 amorphic/amorphic, amorphic/hypomorphic, and hypomorphic/hypomorphic variants. Conclusions: These results broaden the mutational spectrum of DUOX2. Furthermore, our data imply that patients with multiple pathogenic DUOX2 variants typically exhibit transient CH without significant genotype-phenotype correlations. Most importantly, this study demonstrated for the first time that these patients are at risk of developing recurrent hypothyroidism after a long drug-free interval.

来源:Thyroid,查看原文。版权归原作者所有。

引用

  1. Uehara E, Abe K, Tanase-Nakao K, et al. Molecular and Clinical Features of Congenital Hypothyroidism Due to Multiple DUOX2 Variants. Thyroid. 2024. PMID: 38757580. doi:10.1089/thy.2024.0046

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。